Results 121 to 130 of about 53,326 (163)

LAIR1 prevents excess inflammatory tissue damage in Staphylococcus aureus skin infection and Cutaneous T-cell Lymphoma. [PDF]

JCI Insight
Dorando HK, Mutic EC, Tomaszewski KL, Korshunova Y, Tian L, Stefanov MK, Quinn CC, Veis DJ, Bubeck Wardenburg J, Musiek AC, Mehta-Shah N, Payton JE.   +11 more
europepmc   +1 more source

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma. [PDF]

NAR Cancer
Shimauchi T, Murai J, Iwasaki M, Phadungsaksawasdi P, Ojima T, Fujii K, Honda T.   +6 more
europepmc   +1 more source

Erythrodermic cutaneous T-cell lymphoma: Insights from a Kenyan perspective. [PDF]

JAAD Int
Mutio C, Wanyika H, Zuriel D, Ndarathi C.   +3 more
europepmc   +1 more source

An Update on Single-Cell RNA Sequencing in Illuminating Disease Mechanisms of Cutaneous T-Cell Lymphoma. [PDF]

Cancers (Basel)
Suhl S, Kaminsky A, Chen C, Lapolla BA, Zhou MH, Kent J, Marx A, Nebo ID, Ramush G, Luyten S, Sacknovitz Y, Sung J, Bear CM, Schreidah CM, Gru A, Geskin LJ.   +15 more
europepmc   +1 more source

Unraveling the role of chemokines in cutaneous T-cell lymphoma: expression levels at different stages. [PDF]

Front Immunol
Guglielmo A, Zengarini C, Tugnoli F, Zinzani PL, Borghi A, Corazza M, La Placa M, Piraccini BM, Pileri A.   +8 more
europepmc   +1 more source

First report of indolent cutaneous T-cell lymphoma in a fennec fox (Vulpes zerda). [PDF]

Vet Dermatol
Shekelle KL, Glassman AR, Backues KA, Kilburn JJ, Foust-Wheatcraft DA, Stranahan LW.   +5 more
europepmc   +1 more source

Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma. [PDF]

Front Immunol
Melchers S, Tengler L, Şener ÖÇ, Beltzig PL, Schmidt R, Klein S, Utikal JS, Nicolay JP.   +7 more
europepmc   +1 more source

CCR8 Immunohistochemistry Highlights CCR8 as a Diagnostic and Therapeutic Biomarker in Cutaneous T-Cell Lymphoma. [PDF]

J Invest Dermatol
Geller S, Liao V, Moy A, Hollmann TJ, Pulitzer M.   +4 more
europepmc   +1 more source

Targeting FOXM1 regulates metabolic signatures through ROS-dependent JNK/Bmi1/Skp2 axis in human cutaneous T-cell lymphoma. [PDF]

Cell Death Dis
Khan AQ, Agha M, Ahmad F, Anver R, Alam M, Buddenkotte J, Uddin S, Steinhoff M.   +7 more
europepmc   +1 more source

Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma. [PDF]

Blood Adv
Özistanbullu D, Wilhelm R, Reichenbach G, Doll M, Bahrami K, Zöller N, Schnütgen F, König A, Scheller T, Winkler L, Spahn P, Jäger M, Nicolay JP, Pfeilschifter J, Schilling B, Kaufmann R, Koch A, Kippenberger S, Kleemann J, Meissner M.   +19 more
europepmc   +1 more source